Marinus Pharmaceuticals I... (MRNS)
0.55
0.00 (0.00%)
At close: Feb 10, 2025, 3:59 PM
Marinus Pharmaceuticals Cash Flow Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Net Income | -141.41M | -19.82M | -98.78M | -67.47M | -54.12M | -36.73M | -18.9M | -28.64M | -24.85M | -10.83M | -5.27M | -1.41M |
Depreciation & Amortization | 551K | 418K | 355K | 334K | 278K | 127K | 126K | 23K | 11K | 5K | 9.79K | 17.9K |
Stock-Based Compensation | 15.56M | 14.89M | 13.87M | 7.64M | 5.67M | 4.79M | 2.88M | 3.08M | 2.11M | 698K | 236.37K | 120.6K |
Other Working Capital | -2.55M | -4.27M | 20.86M | -3.92M | -1.48M | 6.17M | -779K | 1.4M | -947K | 1.34M | -1.54M | 72.46K |
Other Non-Cash Items | 5.12M | -102.29M | 1.06M | 626K | 94K | -79K | 4K | 7K | 7K | 4K | 90.5K | 305.21K |
Deferred Income Tax | n/a | n/a | -687K | 3K | 34K | n/a | -28K | n/a | 2K | -1.19M | -152.69K | -336.05K |
Change in Working Capital | 2.17M | -6.09M | 28.7M | -2.04M | -590K | 4.05M | -2.9M | 767K | 2.59M | 2.73M | -1.54M | 72.46K |
Operating Cash Flow | -118M | -112.89M | -55.48M | -60.91M | -48.63M | -27.84M | -18.82M | -24.77M | -20.13M | -8.59M | -6.63M | -1.23M |
Capital Expenditures | -119K | -1.77M | -2.89M | n/a | -388K | -83K | -450K | -644K | -352K | -33K | -17.12K | -5.47K |
Acquisitions | n/a | 171K | n/a | n/a | -4.27M | n/a | n/a | n/a | 352K | n/a | n/a | n/a |
Purchase of Investments | -51.99M | -171K | n/a | -8.93M | -2.73M | -24.89M | -24.89M | -2.43M | -7.71M | n/a | n/a | n/a |
Sales Maturities Of Investments | 23.5M | 107.38M | 1.47M | 8.19M | 6.99M | 20M | 3.92M | 4.47M | 1.74M | n/a | n/a | n/a |
Other Investing Acitivies | 9K | 171K | 1.47M | -738K | 4.27M | 24.89M | -20.97M | 2.04M | -352K | n/a | n/a | n/a |
Investing Cash Flow | -28.61M | 105.77M | -1.42M | -738K | 3.88M | 19.92M | -21.42M | 1.4M | -6.31M | -33K | -17.12K | -5.47K |
Debt Repayment | n/a | 58.51M | 40.26M | n/a | n/a | n/a | -5.05M | -2.13M | 28.28M | 6.97M | n/a | 300K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 804K | 1.75M | 1.05M | 1.02M | 97K | 42.12M | 52.64M | -43K | 167K | 128K | 8.03M | 8.58M |
Financial Cash Flow | 26.63M | 124.74M | 41.31M | 109.22M | 67.97M | 42.12M | 47.59M | -2.17M | 28.45M | 48.3M | 8.05M | 8.88M |
Net Cash Flow | -119.98M | 117.62M | -15.58M | 47.57M | 23.22M | 34.2M | 7.35M | -25.54M | 2M | 39.68M | 1.4M | 7.65M |
Free Cash Flow | -118.12M | -114.66M | -58.37M | -60.91M | -49.02M | -27.93M | -19.27M | -25.41M | -20.48M | -8.62M | -6.65M | -1.23M |